Standard Event,Categories,Dummy Cost,Anxiety Inducing,Hospital dependent,Physically Invasiveness,Blood Draw,Sedation,Injection,Urine,Requires Fasting,Longer than 2 hours,Questionnaire
12-lead ECG (central or local),Procedures,140,1,0,1,0,0,0,0,0,0,0
Administer Study Drug,Study Procedures,60,1,0,0,0,0,0,0,0,0,0
Adverse events (AEs),Physical Examination,120,0,0,0,0,0,0,0,0,0,0
Anti-Drug Antibodies,Labs,42,0,0,0,1,0,0,0,0,0,0
Anti-GAD antibodies,Labs,24,0,0,0,1,0,0,0,0,0,0
APP ADL,Questionnaires,54,0,0,0,0,0,0,0,0,0,1
Assess study drug compliance,Study Procedures,60,1,0,0,0,0,0,0,0,0,1
Blood Draw,Labs,36,0,0,0,1,0,0,0,0,0,0
C-Peptide,Labs,30,0,0,0,1,0,0,0,0,0,0
"C-Reactive Protein, high-sensitivity  (hsCRP)",Questionnaires,63,0,0,0,1,0,0,0,0,0,0
C-SSRS Screening/Baseline,Questionnaires,81,1,0,0,0,0,0,0,0,0,1
C-SSRS Since Last Visit,Questionnaires,63,1,0,0,0,0,0,0,0,0,1
Calcitonin,Labs,18,0,0,0,1,0,0,0,0,0,0
CBC,Labs,12,0,0,0,1,0,0,0,0,0,0
Chest x-ray (posterior-anterior and lateral view) (local),Procedures,60,1,0,1,0,0,1,0,0,0,0
Clinician-Administered Assessments (Electronic),Questionnaires,72,1,0,0,0,0,0,0,0,0,1
Clinician-Administered Assessments (Paper),Questionnaires,90,1,0,0,0,0,0,0,0,0,1
Comprehensive Metabolic Panel (Clinical Chemistry),Labs,24,0,0,0,1,0,0,0,0,0,0
Concomitant medications,Physical Examination,60,0,0,0,0,0,0,0,0,0,0
Creatinine,Labs,36,0,0,0,1,0,0,0,0,0,0
Crystatin-C,Labs,12,0,0,0,1,0,0,0,0,0,0
Cytokine Panel,Labs,18,0,0,0,1,0,0,0,0,0,0
Demographics,Physical Examination,48,0,0,0,0,0,0,0,0,0,0
Diary compliance check,Study Procedures,50,0,0,0,0,0,0,0,0,0,0
Diary return,Study Procedures,60,0,0,0,0,0,0,0,0,0,0
Dilated fundoscopic examination,Procedures,100,1,0,1,0,0,0,0,0,0,0
Dispense ancillary supplies to patient,Study Procedures,90,0,0,0,0,0,0,0,0,0,0
Dispense and train on use of blood glucose meter,Study Procedures,60,0,0,0,0,0,0,0,0,0,0
Dispense blood glucose meter,Study Procedures,20,0,0,0,0,0,0,0,0,0,0
Dispense Study Drug,Study Procedures,20,0,0,0,0,0,0,0,0,0,0
DTSQc,Questionnaires,54,0,0,0,0,0,0,0,0,0,1
DTSQs,Questionnaires,54,0,0,0,0,0,0,0,0,0,1
eGFR (CKD-EPI),Labs,36,0,0,0,1,0,0,0,0,0,0
eGFR (MDRD),Labs,12,0,0,0,1,0,0,0,0,0,0
EQ-5D-5L,Questionnaires,54,0,0,0,0,0,0,0,0,0,1
Estradiol,Labs,12,0,0,0,1,0,0,0,0,0,0
Exploratory biomarker samples,Labs,6,0,0,0,1,0,0,0,0,0,0
Flow Cytometry Panel,Labs,48,0,0,0,1,0,0,0,0,0,0
Follicle Stimulating Hormone (FSH),Labs,6,0,0,0,1,0,0,0,0,0,0
Free Fatty Acids,Labs,36,0,0,0,1,0,0,0,0,0,0
Genetics sample,Labs,30,0,0,0,1,0,0,0,0,0,0
Glucagon,Labs,24,0,0,0,1,0,0,0,0,0,0
Glucose,Labs,24,0,0,0,1,0,0,0,0,0,0
HBV DNA,Labs,48,1,0,0,1,0,0,0,0,0,0
Height,Physical Examination,36,0,0,0,0,0,0,0,0,0,0
Hematology,Labs,18,0,0,0,1,0,0,0,0,0,0
Hemoglobin A1c (HbA1c),Labs,12,0,0,0,1,0,0,0,0,0,0
Hepatic Panel (Liver Tests),Labs,6,0,0,0,1,0,0,0,0,0,0
Hepatitis B Virus (HBV) screening tests,Labs,48,1,0,0,1,0,0,0,0,0,0
Hepatitis C Virus (HCV) screening tests,Labs,60,1,0,0,1,0,0,0,0,0,0
HIV screening tests,Labs,54,1,0,0,1,0,0,0,0,0,0
Hypoglycemic events review,Study Procedures,90,0,0,0,0,0,0,0,0,0,0
Immunogencity (ADA) samples,Labs,6,0,0,0,1,0,0,0,0,0,0
Immunoglobulin Panel,Labs,54,0,0,0,1,0,0,0,0,0,0
"Inclusion and exclusion criteria, review and confirm",Study Procedures ,80,0,0,0,0,0,0,0,0,0,0
Informed Assent,Study Procedures ,10,1,0,0,0,0,0,0,0,0,0
Informed consent (assent for pediatrics),Study Procedures ,40,1,0,0,0,0,0,0,0,0,0
Injection Training,Study Procedures ,60,1,0,0,0,0,0,0,0,0,0
Insulin,Labs,12,0,0,0,1,0,0,0,0,0,0
IT-SQ,Questionnaires,81,0,0,0,0,0,0,0,0,0,1
IW-SP,Questionnaires,27,0,0,0,0,0,0,0,0,0,1
IWQOL,Questionnaires,18,0,0,0,0,0,0,0,0,0,1
Lipase,Labs,30,0,0,0,1,0,0,0,0,0,0
Lipid panel,Labs,60,0,0,0,1,0,0,0,1,0,0
Observe patient administer study drug,Study Procedures ,60,1,0,0,0,0,0,0,0,0,0
Pancreatic Amylase,Labs,36,0,0,0,1,0,0,0,0,0,0
Patient Diary (Electronic),Study Procedures ,60,0,0,0,0,0,0,0,0,0,1
Patient Diary (Paper),Study Procedures ,80,0,0,0,0,0,0,0,0,0,1
Patient diary dispensed,Study Procedures ,10,0,0,0,0,0,0,0,0,0,0
Patient Education,Study Procedures ,50,0,0,0,0,0,0,0,0,0,0
Patient Reported Ouctomes (Electronic),Study Procedures,30,1,0,0,0,0,0,0,0,0,1
Patient returns study drugs and injection supplies,Study Procedures,90,0,0,0,0,0,0,0,0,0,0
Patient-Reported Outcomes (Paper),Study Procedures,90,1,0,0,0,0,0,0,0,0,1
Pharmacokinetic (PK) samples,Labs,42,0,0,0,1,0,0,0,0,0,0
PHQ-9,Questionnaires,54,0,0,0,0,0,0,0,0,0,1
Physical examination,Physical Examination,48,1,0,0,0,0,0,0,0,0,0
PK sample for immunogenicity,Labs,42,0,0,0,1,0,0,0,0,0,0
"Preexisting conditions and medical history, including relevant surgical history",Physical Examination,12,0,0,0,0,0,0,0,0,0,0
Prespecified medical history (indication and history of interest),Physical Examination,36,0,0,0,0,0,0,0,0,0,0
Prior treatments for indication,Physical Examination,12,0,0,0,0,0,0,0,0,0,0
Randomization and Dosing,Study Procedures,40,0,0,0,0,0,0,0,0,0,0
Randomization/IWRS,Study Procedures,90,0,0,0,0,0,0,0,0,0,0
Self-Harm Follow-Up Form,Questionnaires,27,1,0,0,0,0,0,0,0,0,1
Self-harm Supplement Form,Questionnaires,9,1,0,0,0,0,0,0,0,0,1
Serum pregnancy,Labs,54,0,0,0,1,0,0,0,0,0,0
SF-36,Questionnaires,90,0,0,0,0,0,0,0,0,0,1
SMBG Profile,Study Procedures,80,0,0,0,0,0,0,0,0,0,0
Stored Samples,Labs,6,0,0,0,1,0,0,0,0,0,0
Study Drug Dose Adjustment,Study Procedures,50,0,0,0,0,0,0,0,0,0,0
Study Drug Dose Calculation - Initial,Study Procedures,50,0,0,0,0,0,0,0,0,0,0
"Substance use (alcohol, caffeine, tobacco use)",Physical Examination,36,1,0,0,0,0,0,0,0,0,0
Symptom-directed physical examination,Physical Examination,120,0,0,0,0,0,0,0,0,0,0
Telephone Call,Study Procedures,70,0,0,0,0,0,0,0,0,0,0
Thyroid Stimulating Hormone (TSH),Labs,54,0,0,0,1,0,0,0,0,0,0
Tuberculosis (TB) Test,Labs,42,0,0,0,1,0,1,0,0,0,0
Urinalyis,Labs,18,0,0,0,1,0,0,1,0,0,0
Urinary albumin/creatinine ratio (UACR),Labs,24,0,0,0,1,0,0,0,0,0,0
Urine pregnancy (local),Labs,42,0,0,0,1,0,0,0,0,0,0
Vital Signs,Physical Examination,12,1,0,0,0,0,0,0,0,0,0
Waist Circumference,Physical Examination,60,0,0,0,0,0,0,0,0,0,0
Weight,Physical Examination,84,0,0,0,0,0,0,0,0,0,0